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The status of vitamin D in underground working coal miners and its association with
their cardiometabolic health is rarely studied. This study aimed to examine vitamin D
(VitD) status in Serbian underground coal miners and to correlate it with anthropometric
and laboratory indicators of cardiometabolic risk. Nutritional data (food frequency
questionnaire, FFQ, and two times repeated 24 h recall), anthropometric data (including
segmental analysis by bio-impedance analyzer TANITA BC-545N), arterial tension, and
biochemical and hematological data of 103 coal miners (aged 22–63 years) were
correlated with their late summer (early September) serum 25 (OH)D levels (measured
by HPLC). 68.9% of the studied coal miners were overweight/obese, and 48.5% had
metabolic syndrome. Their mean VitD nutritional intakes were low: 5.3 ± 3.8 µg/day
(FFQ) and 4.9 ± 8 µg/day (24 h recalls), but their mean serum 25 (OH)D levels were
surprisingly high (143.7 ± 41.4 nmol/L). Only 2.9% of the coal miners had 25(OH)D
levels lower than 75 nmol/L (indicating an insufficient/deficient status), while 63.2% had
values above 125 nmol/L (upper optimal limit), and even 10.7% had values above 200
nmol/L. There were no statistical differences in 25 (OH)D levels in the coal miners with
or without metabolic syndrome (or overweight/obesity). Interestingly, 25(OH)D levels
had significant positive correlations with body mass index (BMI), fat mass (FM), fat
mass percentage (FM%), limbs FM%, serum triglycerides, GGT, AST, ALT, and ALT/AST
ratio, and had significant negative correlations with serum HDL-cholesterol and age.
All these correlations were lost after corrections for age, FM, FM%, and legs FM%. In
Serbian coal miners, high levels of early September VitD levels were observed, indicating
sufficient non-working-hour sun exposure during the summer period. Furthermore, the
unexpected positive correlations of VitD levels with anthropometric and biochemical
parameters indicative of obesity, metabolic syndrome, and fatty liver disease were found.
More research is needed on the VitD status of coal miners (particularly in the winter period)
and its relationship with their cardiometabolic status.
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INTRODUCTION
The relationship between vitamin D (VitD) status and obesity,
metabolic syndrome, diabetes, and cardiovascular diseases has
gained scientific attention over the last decades. Low serum
vitamin D levels have been associated with obesity, metabolic
syndrome, and increased risk for diabetes and cardiovascular
diseases (1–4). However, inconsistent findings exist, and
cause/effect relationships still need to be confirmed (1–5).
On the other hand, in parallel with the increasing worldwide
prevalence of obesity, metabolic syndrome, diabetes, and
cardiovascular diseases (6–8), with the latter two being among
the first four leading causes of death across the world, there
is an increasing prevalence of VitD insufficiency/deficiency
(9, 10). Some populations are at increased risk for low VitD
levels (10–12). The modern lifestyle in big cities, with high
buildings, air pollution, and low insolation of streets; everyday
commuting by closed vehicles and predominantly indoor work
and leisure activities (without enough outdoor activities and
direct exposure to the sun), leads to an increased prevalence of
VitD insufficiency/deficiency among populations (10, 13) where
it was not expected to appear (e.g., in regions with low latitude
and high insolation) (14, 15). Some professions and working
conditions aremore associated with lowVitD levels. For example,
shift work, night work, and working indoors, without direct sun
exposure, are associated with lower VitD serum levels (16, 17).
All of those are characteristics of underground mining work.
Nevertheless, insufficient data exist on the serum levels of VitD
in this population of workers (17–21), and the data do not show
the lower levels compared with the general population or surface
workers from the same geographic region (17–21). Therefore,
more data are needed on this topic. Furthermore, there are
insufficient data on the cardiometabolic status of coal miners,
with only few recently published studies (22–26).
Given that, this study aimed to examine the following: (1) the
levels of serum VitD among a sample of underground working
coal miners in Serbia; (2) the anthropometric and biochemical
indicators of cardiometabolic risk among them; (3) the
association of VitD levels with indicators of cardiometabolic risk.
MATERIALS AND METHODS
Participants and Study Design
This cross-sectional study included 103 male coal miners, aged
22–63 years, from the underground Brown Coal Mine “Rembas”
(shaft “Vodna,” Strmosten), in the Resavica coal mining basin
in Serbia, who during the period May 9, 2016, to September
9, 2016, (late summer) underwent their periodic (annual)
preventive systematic medical examinations, obliged by the law
and performed by the Institute of Occupational Medicine Niš.
The study was a joint project of the Institute of Medical Research
of the University of Belgrade and the Institute of Occupational
Medicine Nis and supported by the Ministry of Education,
Science and Technological Development of the Republic of
Serbia. The study was in accordance with the ethical principles
of the Declaration of Helsinki and approved by the Institute of
Occupational Health Niš Ethics Board.
According to official data (27), in 2016, in Serbia, there
were 2,750 underground coal miners, working in shafts, and
the vast majority of them were employed in the Resavica
basin (76.4%). The required study sample size was 45 subjects,
which was calculated according to the previously published
data on summer Serbian general male population VitD levels
(28) and the decided precision (margin of error) of ± 5
nmol/L at 95% confidence level, and the formula: needed
sample size = (1.96)2 ∗ (SD)2/(decided precision)2 (29).
Considering possible unfitness, dropout, and planned further
correlation analyses, we decided to initially include (i.e., invite
to participate in the study) all 140 employed miners in this
coal mine who attended their preventive systematic medical
examinations, which would represent about 5% of Serbian
coal miners.
On the day of the examination, the coal miners attended the
center for preventive medical checkups at 07:00, after fasting
overnight for 12 h. Detailed examinations to obtain information
on their health were performed by medical specialists (including
specialists of occupational health and internal medicine), and
incorporated, inter alia, blood pressure measurements and
fasting blood, and urine sampling for laboratory biochemical
analyses. Supplementary analyses for this study involved the
following: (1) anthropometric measures (including, among
others segmental body composition analysis by bioelectrical
impedance, BIA); (2) dietary surveys [such as the two times
repeated 24 h recall and FFQ, which was validated for VitD intake
(30)], (3) and further analyses of the obtained biochemical serum
samples to determine VitD status by high-performance liquid
chromatography (HPLC).
From the 140 coal miners who attended the medical
preventive checkups and were invited to participate in the study,
a total of 103 agreed to participate in the study, signed written
consent, and performed all the tests and analyses required
for this study (i.e., the participants who did not manage to
perform all of the required examinations, presented here, or
fulfilled the exclusion criteria, were excluded from the study).
The exclusion criteria were the following: the presence of
serious medical conditions; established diagnosis of diabetes
mellitus with regular use of glucose-lowering therapy; established
diagnosis of hyperlipidemia with regular use of lipid lower
drugs; a known liver disease with non-metabolic etiology,
excluding non-alcoholic fatty liver disease (NAFLD); taking
any antihypertensive and glucose/lipid-lowering agents in the
previous 24 h).
All the underground miners worked in three rotating shifts
(2 days in first shift: 07:00–15:00; 2 days in second shift: 15:00–
23:00; 2 days in third shift: 23:00–07:00; then, 2 days off) and
always stayed underground, in the shaft during their shifts. They
all performed heavy physical work (31), such as hewing coal,
loading coal, and erecting roof supports.
Anthropometric Measurements and
Measurement of Arterial Tension
Measurements of body height, body weight, fat mass (FM), fat
mass percentage (FM%), fat-free mass (FFM), muscle mass, bone
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mass, waist circumference, and hip circumference were taken by
a trained medical doctor, following standard techniques (32, 33).
The subjects were measured fasted at 8 am, after emptying their
bladder and bowels, wearing only underwear. Body height was
measured to the nearest 0.01mwith a wall-mounted stadiometer.
Bodyweight, FM, FM%, FFM, muscle mass, and bone mass were
measured on a portable scale Tanita Inner Scan V BC-545N
Segmental Body Composition Monitor (Tanita, Aerolit d.o.o.,
Belgrade, Serbia), by BIA. The body weight was measured to the
nearest 0.1 kg. The measurements were performed according to
the recommendations provided by the manufacturer. Additional
segmental analyses included muscle mass of trunk, arms, and
legs; fat percentage of the trunk, arms, and legs; and visceral fat
level (VFL), calculated according to the Tanita algorithm by the
BIA segmental body analysis (34, 35). Body mass index (BMI:
kg/m2) was calculated by dividing the weight (in kilograms) by
the square of height (in meters), and according to their BMI,
the coal miners were classified into three groups: normal weight
(BMI: 18.5–24.9 kg/m2), overweight (BMI: 25–29.9 kg/m2), and
obese (BMI 30 kg/m2) (36). Increased adiposity was defined
according to %FM ≥ 21–22 (depending on age) (37). Waist
and hip circumferences were measured with a flexible, stretch-
resistant tape, to the nearest centimeter. Waist circumference
was measured at the approximate midpoint between the lower
margin of the last palpable rib and the top of the iliac crest, at
minimum respiration. Hip circumference was measured at the
widest points over the hip at the level of the greater trochanter,
with the tape parallel to the floor (33). Abdominal obesity was
defined by waist circumference ≥ 102 cm (33). Supplementary
calculations included waist to hip ratio (WHR), and WHR≥0.91
was considered as indicative of centripetal obesity, i.e., truncal fat
distribution (33).
Arterial blood pressures were measured in the morning,
after sitting for at least 10min, on the left upper arm, with
a calibrated mechanic sphygmomanometer and stethoscope
(Becton Dickinson, Franklin Lakes, NJ, United States), and
the average of two measurements was presented as the result.
Hypertension was defined by systolic blood pressure ≥ 140
mmHg and/or diastolic blood pressure ≥ 90 mmHg, while pre-
hypertension was defined by systolic blood pressure between 130
and 140 mmHg and/or diastolic blood pressure between 85 and
90 mmHg (38).
Laboratory Biochemical Analyses of Blood
Samples
Fasting blood samples were collected between 07:00 and
08:00 in specific Vacutest Kima R© blood collection tubes,
available from Vacutest Kima R© S.R.L., Italy (Yunycom d.o.o.,
Belgrade, Serbia), including the following: Vacutest R© Kimased
sodium citrate 3.8% 1.6ml tubes (for erythrocyte sedimentation
rate, tubes, erythrocyte sedimentation rate (ESR), analysis),
Vacutest R© K3EDTA 3ml tubes (for blood cell count, hematocrit,
and hemoglobin analysis), Vacutest R© Serum Separator Clot
Activator 6ml tubes for analysis of serum glucose, total
cholesterol, high-density lipoproteins (HDL)-cholesterol and
low-density lipoproteins (LDL)-cholesterol, triglycerides, urea,
creatinine, total bilirubin, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase (ALP),
gamma-glutamyl transferase (GGT), and VitD.
Following the instructions of the manufacturer for processing
and handling of the blood collection tubes, ESR analyses
were performed with the Westergren’s method at 18◦C, using
the Kimased ESR rack with scaling. One-hour Westergren
values were determined by reading the distance (in mm)
from the plasma meniscus to the top of the column of
sedimented erythrocytes 30min, immediately (maximum 1h)
after blood collection. Analyses of blood cell counts, hematocrit,
and hemoglobin were performed on Phoenix NCCNCC-2310
(NeoMedica d.o.o., Nis, Serbia), and the serum coagulation tubes
(after allowing them to clot for at least 30min in an upright
position at room temperature) were centrifuged at 3,000 × g for
10min at room temperature. Following centrifugation, standard
photometric assays were performed using an ARCHITECT
c8000 Abbott clinical chemistry analyzer (Abbott Laboratories
S.A., Belgrade, Serbia), and commercially available kits (Abbott
Laboratories S.A., Belgrade, Serbia). Intra- and inter-assay
coefficients of variation (CVs) for all measurements were <5%.
The criteria for the existence of diabetes and impaired fasting
glucose were set according to the American Diabetes Association
(ADA) 2016 guidelines (39). The existence of dyslipidemia
was established based on the National Cholesterol Education
Program—Adult Treatment Panel III (NCEP-ATP III) criteria
from 2001 (40). The atherogenic risk was also calculated as
the ratio of total cholesterol/HDL-cholesterol, the ratio of LDL-
cholesterol/HDL-cholesterol, and the ratio of triglycerides/HDL-
cholesterol, as all of these ratios have clinical implications (41,
42). Metabolic syndrome was defined according to the American
Heart Association/National Heart, Lung, and Blood Institute
(AHA/NHLBI) 2005 criteria (43).
Serum VitD Analysis by HPLC Method
Serum total 25 (OH) vitamin D, calculated as a sum of 25
(OH) vitamin D2 and 25 (OH) vitamin D3, was determined
using an Agilent 1100 series HPLC system equipped with
a diode array detector (DAD) and the RECIPE’s (RECIPE
Chemicals+ Instruments GmbH, Munich, Germany) ClinRep R©
HPLC Complete Kit for 25 (OH) VitD2/D3 in plasma and
serum (containing a ClinTest R© Test Solution, ClinCal R© Serum
Calibrators, ClinChek R© Serum Controls, sample preparation
vials, the precipitation agent, internal standard, mobile phase,
and analytical column), according to the instructions of
the manufacturer.
Immediately after the analyses with the ARCHITECT c8000
clinical chemistry analyzer were performed, 1.5ml of serum was
separated from the serum coagulation tubes in 2ml Eppendorf
microtubes and kept frozen at −80◦C in a freezer until further
VitD assays were performed.
After 24 months of storage at −80◦C (which should not
influence the results, since vitamin D is quite stable during
prolonged storage at −80◦C, up to 6–30 years) (44, 45), serum
samples were defrosted and vortex-mixed and 0.4ml of the
samples were transferred to the sample preparation vials, filled
with 0.5ml of the precipitation agent. Afterward, 0.4ml of
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internal standard was added (cooled at temperature−20◦C), and
the vials were vortex-mixed for 30 s and centrifuged for 5min
at 10,000 × g. After centrifugation, 50 µl of the upper liquid
phase of the supernatant was injected into the Aligent 1100
HPLC system, with a flow rate of 1 ml/min, and the column
heater at 40◦C. The sample components were separated on the
analytical column, and the analytes, 25 (OH) VitD2 and 25 (OH)
VitD3, were detected with the DAD detector at a wavelength of
264 nm, with retention times of 7.3 and 6.4min, respectively.
Quantification was performed comparing the peak areas of 25
(OH) VitD2 and 25 (OH) VitD3 with the peak area of the
internal standard (its retention time was 8.3min). In addition,
the ClinChek R© Serum Controls were used after running every
10 examined samples to perform quality control. The precision
of measurement (expressed as CVs) for 25 (OH) VitD2 and 25
(OH) VitD3 was 6.5 and 6%, respectively.
Taking into consideration different cutoff values for defining
VitD deficiency/insufficiency (9, 10, 46–48), the serum levels
of 25 (OH) VitD below 50 nmol/L were defined as a deficient
state, while those between 50 and 75 nmol/L were defined as an
insufficient state (9). Deficiency below 50 nmol/L was defined
as mild to moderate and below 30 nmol/L was defined as
severe (10). The values above 175 nmol/L were defined as mildly
increased, above 200 nmol/L was defined as moderately increased
(the lowest literature-reported level associated with toxicity
in subjects with normal renal function and without primary
hyperparathyroidism), and above 250 nmol/L was defined as
excessive (hypervitaminosis) (46). The values between 75 and 175
nmol/L were defined as VitD sufficiency (“normal range”), while
the values between 75 and 125 nmol/L were defined as “optimal.”
(46, 49).
Assessment of Dietary Intakes
Dietary intake data were collected by a trained medical doctor
using a validated food frequency questionnaire (FFQ) (30) and
the two times repeated 24 h recall method, in accordance with the
European Food Safety Authority (EFSA) EUMenu methodology
(32, 50). The FFQ and the first 24 h recall were performed
on the day of physical examination and blood sampling, while
the second 24 h recall was performed with a minimum of 7
days apart, by a telephone call. The average intakes of energy,
macronutrients, and VitD were calculated with the DIET ASSESS
& PLAN (DAP) software (51, 52), which was evaluated by
the EFSA (32, 50) using the national validated Food Atlas for
Portion Size Estimation (53) and Serbian Food Composition
Database, developed in compliance with EuroFIR standards (54).
Calculated data for VitD intakes were evaluated by comparison
with the adequate intake (AI) defined by the EFSA in 2016 (i.e.,
minimum 15 µg/day for adults) (48).
Statistical Analysis
Statistical analyses were performed using the SPSS 22.0 (SPSS
Inc., Chicago, IL, United States) statistical software. Data
are presented as the mean ± SD, along with minimum and
maximum values. The normality of data distribution was
tested by the Kolmogorov–Smirnov test. Differences in VitD
levels between subjects with and without overweight/obesity
or metabolic syndrome were analyzed by the Mann–Whitney
U-test. Correlation between VitD levels and biochemical
data, anthropometric measurements, daily energy, and
macronutrient/micronutrient nutrient intake was assessed
by Pearson’s correlation coefficient (for parametric data)
and Spearman’s correlation coefficient (for non-parametric
data). Partial correlations were used when one or more
controlling variables were included in the analyses. Linear
stepwise regression models were made to explore the strength
and independence of associations between VitD levels and
characteristics of analyzed subjects. P-value was expressed
as a number rounded up to three decimal places; statistical
significance was assumed at a two-tailed P < 0.05.
RESULTS
Descriptive Statistics: Characteristics of
the Studied Population of Coal Miners
Table 1 presents general, anthropometric, and blood pressure
data, Table 2 presents the data on biochemical analyses,
and Table 3 gives the data on dietary intakes of energy,
macronutrients, and VitD.
The mean age was 40.6± 9.6 years, but 10-year age categories
were not represented equally, and only 11.7% of the participants
were above 52-year-old (Supplementary Figure 1). More than
half (53.5%) of the participants were smokers, and the huge
majority (79.6%) lived in rural areas (the rest lived in semi-
urban areas).
The average BMI belonged to the category of overweight
(27.2 ± 4.5 kg/m2), and almost half of the participants (45.6%)
were overweight, while about one-quarter (23.3%) were obese,
with these two BMI categories making together above two-
third of the studied population (68.9%). Less than one-third
(28.2%) had normal weight, and only 2.9% were underweight.
Almost half of the participants (45.6%) had increased adiposity,
according to % FM ≥ 21–22 (depending on age). According to
waist circumference, almost half of the participants (45.6%) had
abdominal obesity, even though the average waist circumference
value was under the cutoff value for abdominal obesity (i.e., <
102 cm). Centripetal obesity/fat distribution according to WHR
was present in 75.7% of the participants.
The average measured values of fasting serum glucose
(Table 2) were above the ADA cutoff values for the diagnosis
of impaired fasting glucose (“pre-diabetes”), and 63.1% of the
participants had serum glucose values above this value (i.e.,
≥5.6 mmol/L), while at the same time 11.7% of the participants
also met the criteria for diabetes (i.e., fasting serum glucose
≥ 7 mmol/L). Also, the average blood lipid levels were above
the ATP III cutoff values for triglycerides (i.e., ≥1.69 mmol/L),
total cholesterol (i.e., ≥5.17 mmol/L), and LDL-cholesterol (i.e.,
≥3.34 mmol/L), while the average HDL-cholesterol levels were
below the recommended values for men (i.e., <1.03 mmol/L)
(Table 2). In total, 53.4, 62.1, and 45.6% of the participants
had elevated triglycerides, total cholesterol, and LDL-cholesterol,
respectively, while only 26.2% of the participants had reduced
HDL-cholesterol levels. In total, 84 participants (81.6%) had
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TABLE 1 | Demographic, anthropometric, and arterial BP data of the studied coal miners (N = 103, men), and correlation with serum 25 (OH) vitamin D levels.









(adjusted for age, FM,
FM%, and legs FM%)
Mean SD (Min–Max) r r r
Age (years) 40.6 9.6 (22.0–63.0) −0.283**
Body height (cm)§ 177.4 6.5 (162.0–196.0) 0.014 −0.116 −0.124
Body weight (kg) 86.0 16.6 (49.4–126.3) 0.201* 0.068 0.034
BMI (kg/m2 ) 27.2 4.5 (16.5–38.1) 0.243* 0.205* 0.185
FM (kg) 18.0 8.9 (2.7–39.2) 0.210*
FM% (%) 19.9 7.2 (5.0–36.2) 0.200*
FFM (kg) 68.1 9.8 (40.6–88.8) 0.150 0.068 0.034
Muscle mass (kg) 64.7 9.4 (38.4–84.6) 0.151 0.070 0.036
Skeletal mass (kg) 3.4 0.5 2.1–4.3) 0.159 0.081 0.048
Segmental analysis
Arms FM% (%) 18.1 5.9 (4.6–39.4) 0.162 −0.076 −0.137
Trunk FM% (%) 21.2 8.6 (5.0–35.9) 0.171 −0.163 0.148
Legs FM% (%) 18.4 6.4 (3.8–42.7) 0.250* 0.208*
Arms muscle mass (kg) 7.8 1.4 (3.7–12.1) 0.194* 0.149 0.090
Trunk muscle mass (kg) 35.2 5.1 (21.6–48.8) 0.120 0.078 0.022
Legs muscle mass (kg) 21.7 3.2 (13.1–28.9) 0.182 0.007 0.046
VFL 8.0 4.2 (1.0–18.5) 0.077 0.046 0.167
Waist circumference (cm) 98.9 12.9 (69.0–129.0) 0.143 −0.032 −0.050
Hip circumference (cm) 104.4 8.3 (86.0–124.0) 0.211* 0.091 0.074
WHR 0.95 0.07 (0.78–1.11) 0.021 −0.098 −0.104
Systolic BP (mmHg)§ 127.1 14.2 (100.0–160.0) 0.059 0.091 0.105
Diastolic BP (mmHg)§ 83.1 8.0 (60.0–120.0) −0.005 0.034 0.025
§Spearman’s rank correlation coefficients—rs (otherwise—data represent Pearson’s correlation coefficients—r).
Bolded coefficients are statistically significant.
*p < 0.05; correlation is significant at the 0.05 level (two-tailed).
**p < 0.01; correlation is significant at the 0.01 level (two-tailed).
BMI, body mass index; FM, fat mass; FM%, percentage of fat mass; FFM, fat-free mass; VFL, visceral fat level; WHR, waist to hip ratio; BP, blood pressure; SD, standard deviation;
r, Pearson’s correlation coefficients; rs, Spearman’s rank correlation coefficients; p, statistical significance of correlations.
dyslipidemia according to at least one of the ATP III criteria,
while 11 participants (10.7%) fulfilled all the ATP III criteria for
dyslipidemia (at the same time having increased triglycerides and
LDL-cholesterol levels, and decreased HDL-cholesterol levels).
The ratios of total cholesterol, LDL-cholesterol, and triglycerides
to HDL-cholesterol were increased (i.e., respectively, ≥5, ≥3.3,
and≥0.87) in 43.7, 34, and 73.8% of the participants, respectively.
The average systolic and diastolic pressures were in the normal
range, but 51.5% of the participants met the criteria for pre-
hypertension or hypertension.
Only three participants used lipid-lowering agents (but
they did not use them regularly), while 11 participants used
antihypertensive drugs. No other medicaments used were
reported, and no medications were used on the morning of
the examination.
According to the obtained data on glucose, triglycerides,
HDL-cholesterol, blood pressure, and waist circumference (or
regular use of relevant medicaments), 48.5% of the participants
fulfilled the 2005 AHA criteria for the diagnosis of metabolic
syndrome. The serum levels of ALT above 30 U/L, GGT
above 30 U/L, and ALT/AST ratio higher than 1.25 [indicative
for NAFLD (55–57)] had 36.9, 48.5, and 40.8% of the
participants, respectively.
The average energy intake, according to the repeated 24 h
recalls, was 3955.2 ± 1095.4 kcal/day, which is in accordance
with existing recommendations (58), but there was a huge inter-
individual difference (individual intakes ranged from 1,600 to
7,200 kcal) (Table 3). On average, proteins, fats, carbohydrates,
and alcohol provided 12.9 ± 2.1, 46.8 ± 6.7, 38.1 ± 7.1, and 2.2
± 3.5% of total daily energy intake, respectively. Daily alcohol
intake (average for 2 days, according to 24 h recalls) varied from
0 g (in 54.4% of coal miners) to 126.7 g. Similarly, according to
FFQs, only 58.3% of the coal miners reported alcohol intake.
The average intake of VitD was quite low and far below the
recommended values by EFSA: 5.3 ± 3.8 µg/day (according to
FFQs) and 4.9 ± 8 µg/day (according to 24 h recalls) (Table 3).
Only two of the participants had an adequate nutritional intake
of VitD, above 15 µg/day. There was a statistically significant
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TABLE 2 | Hematological and biochemical data of the studied coal miners (N =103, men), and correlation with serum 25 (OH) vitamin D levels.





(adjusted for age, FM,
and FM%)
Correlation with vitamin D
levels
(adjusted for age, FM,
FM%, and legs FM%)
Mean SD (Min–Max) rs rs rs
ESR (mm/h) 6.8 3.5 (3.0–22.0) −0.112 −0.037 −0.026
WBC (× 109/L) 7.8 2.1 (3.8–14.4) 0.038 0.018 0.003
RBC (× 1012/L) 5.0 0.5 (3.2–6.3) 0.208* 0.129 0.096
HGB (g/L) § 155.1 10.1 (135.0–183.0) 0.142 0.073 0.047
HCT (L/L)§ 0.4 0.0 (0.3–0.5) 0.144 0.112 0.096
MCV (fL)§ 87.8 5.1 (69.3–102.4) −0.169 −0.036 −0.013
MCH (pg) 30.9 2.4 (23.0–41.2) −0.108 −0.059 −0.058
MCHC (g/L) 352.7 17.7 (324.0–430.0) 0.022 −0.065 −0.077
PLT (× 109/L) 240.2 56.7 (131.0–427.0) −0.028 0.001 −0.012
Glucose (mmol/L) 6.0 1.2 (3.5–11.5) −0.015 −0.030 −0.037
Triglycerides (mmol/L) 2.0 1.0 (0.5–4.9) 0.249* 0.237* 0.190
Total cholesterol (mmol/L) 5.8 1.3 (3.5–9.8) 0.169 0.198* 0.135
LDL-cholesterol (mmol/L) 3.4 1.1 (1.1–7.5) 0.118 0.134 0.071
HDL-cholesterol (mmol/L) 1.3 0.4 (0.7–2.7) -0.250* −0.209* −0.145
TC/HDL 5.0 2.0 (1.5–11.5) 0.300** 0.293** 0.220*
LDL/HDL 2.9 1.4 (0.4–7.4) 0.245* 0.235* 0.159
TG/HDL 1.9 1.4 (0.2–7.1) 0.273** 0.251* 0.192
AST (U/L) 24.5 7.5 (12.0–64.0) 0.235* 0.194 0.191
ALT (U/L) 30.3 14.8 (11.0–93.0) 0.351** 0.254* 0.187
ALT/AST 1.23 0.43 (0.58–2.44) 0.276* 0.170 0.089
GGT (U/L) 37.3 31.0 (10.0–245.0) 0.203* 0.165 0.107
ALP (U/L) 56.3 16.4 (14.0–99.0) 0.084 −0.002 0.007
Total bilirubin (µmol/L) 11.7 6.6 (3.7–35.4) −0.169 −0.191 −0.198
Urea (mmol/L) 4.9 1.0 (2.8–8.3) 0.036 0.097 0.089
Creatinine (µmol/L) 72.8 10.1 (54.5–120.3) 0.244* 0.207* 0.157
§Pearson’s correlation coefficients—r (otherwise—data represent Spearman’s rank correlation coefficients—rs ).
Bolded coefficients are statistically significant.
*p < 0.05; correlation is significant at the 0.05 level (two-tailed).
**p < 0.01; correlation is significant at the 0.01 level (two-tailed).
FM, fat mass; FM%, percentage of fat mass; ESR, erythrocyte sedimentation rate; WBC, white blood cell count; RBC, red blood cell count; HGB, hemoglobin; HCT, hematocrit;
MCV, mean volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet count; LDL, low-density lipoprotein; HDL, high -
density lipoprotein; TC/HDL, total cholesterol/HDL-cholesterol ratio; LDL/HDL, LDL-cholesterol/HDL-cholesterol ratio; TG/HDL, triglycerides/HDL-cholesterol ratio; AST, aspartate
aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyl transferase; SD, standard deviation; rs, Spearman’s rank correlation coefficients; r,
Pearson’s correlation coefficients; p, statistical significance of correlations.
correlation between VitD intakes by FFQs and 24 h recalls
(Spearman’s rho correlation coefficient 0.268, p = 0.04). Only
four of the coal miners consumed supplements of VitD.
Vitamin D Status
The average value of serum 25(OH) vitamin D was way above the
lower cutoff value for the sufficient state: 143.7 ± 41.4 nmol/L,
ranging from 43.5 to even 247.5 nmol/L. Only three (2.9%) of the
coal miners had levels of VitD lower than 75 nmol/L (indicating
an insufficient/deficient status, with two subjects having mild
deficiency), while 63.2% had values above 125 nmol/L (upper
optimal limit). In total, 22.3% of the coal miners had 25(OH)
VitD above 175 nmol/L (the upper limit for normal range), and
even 10.7% had values above 200 nmol/L (the lowest literature-
reported level associated with toxicity). None of the coal miners
had VitD values above 250 nmol/l (hypervitaminosis) (For
graphical presentation, refer to Supplementary Figure 2.)
Most of the total serum 25 (OH) VitD was 25(OH) vitamin D3
(143.5± 41.4 nmol/L, ranging from 43.5 to 247.5 nmol/L), while
25(OH) VitD2 made only a small part (0.2± 1.6 nmol/L, ranging
from 0 to 15 nmol/L).
The results on 25 (OH) VitD levels were not much different
if the subjects who consumed supplements of VitD were
excluded from the analysis (mean total serum 25 (OH) VitD
was 144.1 ± 42.1 nmol/L, again ranging from 43.5 to 247.5
nmol/L). Considering the four coal miners who consumed the
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TABLE 3 | Nutritional intakes data of the studied coal miners (N =103, men), and correlation with serum 25 (OH) vitamin D levels.





(adjusted for age, FM,
and FM%)
Correlation with vitamin D
levels
(adjusted for age, FM,
FM%, and legs FM%)
Mean SD (Min–Max) rs rs rs
Total caloric intake (kcal/d) 3955.2 1095.4 (1609.0–7170.2) 0.119 0.117 0.078
Protein intake (kcal/d) 509.8 171.2 (186.2–1199.0) 0.056 0.050 0.022
Fat intake (kcal/d) 1851.6 565.6 (864.0–3547.5) 0.018 0.045 0.019
Carbohydrates intake (kcal/d) 1497.4 504.4 (492.4–2963.6) 0.167 0.144 0.106
Alcohol intake (kcal/d) 96.4 157.6 (0.0–886.9) 0.158 0.123 0.088
Total caloric intake (kcal/d)–day 1§ 3957.8 1190.3 (2025.0–7284.4) 0.182 0.181 0.158
Protein intake (kcal/d)–day 1§ 510.4 181.3 (228.8–1036.3) 0.116 0.121 0.101
Fat intake (kcal/d)—day 1§ 1830.1 639.7 (514.8–3634.4) 0.080 0.081 0.072
Carbohydrates intake (kcal/d) – day 1§ 1533.1 568.0 (419.0–3288.0) 0.211* 0.186 0.162
Alcohol intake (kcal/d) – day 1§ 84.3 188.0 (0.0–1108.8) 0.225* 0.192 0.135
Vitamin D intake (µg/d) 4.9 8.0 (1.1–65.2) −0.089 −0.063 −0.079
Vitamin D intake (µg/d) – day 1§ 5.5 11.4 (0.9–98.0) −0.040 −0.015 −0.033
Vitamin D intake FFQ (µg/d)U 5.3 3.8 (1.2–18.5) −0.007 −0.139 −0.170
§Data referring only to the first 24 h recall, representing the day before sampling of blood (otherwise—data represent the mean of two recalls).
UData derive from FFQ (otherwise—data derive from 24-h recalls, representing the mean of two recalls, or only referring to day 1, the day before sampling of blood).
Bolded coefficients are statistically significant.
*p < 0.05; correlation is significant at the 0.05 level (two-tailed).
FM, fat mass; FM%, percentage of fat mass; FFQ, food frequency questionnaire; SD, standard deviation; rs, Spearman’s rank correlation coefficients; p, statistical significance
of correlations.
supplements, their VitD levels ranged from 105.5 to 149.5 nmol/L
(in average 123.2 ± 18.7 nmol/L), only nine subjects were
sunbathing by the seaside during the summer, and the levels of
VitD were statistically marginally higher in them: 172.3 ± 46.5
vs. 141± 40.1 nmol/L (Mann–Whitney test p= 0.05).
There was no statistically significant difference in VitD levels
between those who lived in rural and semi-urban areas (141.6
± 42.2 vs. 152.1 ± 37.6 nmol/L, respectively), or smokers and
non-smokers 140.8± 43.2 vs. 146.4± 40.3 nmol/L, respectively).
There was no correlation between serum 25 (OH) VitD levels
and VitD nutritional intake, according to both FFQs and 24 h
recalls (Table 3).
When only nutritional data from the day before blood
sampling were analyzed, VitD levels correlated with 24 h recall
carbohydrates and alcohol intake the previous day (Table 3).
Association of VitD Levels With
Cardiometabolic (Anthropometric and
Biochemical) Parameters
There were no statistically significant difference in 25 (OH) VitD
levels in the coal miners with or without metabolic syndrome, or
with or without overweight/obesity (148.9± 42.0 vs. 138.8± 40.5
nmol/L, and 147 ± 37.1 vs. 136.4 ± 49.5 nmol/L, respectively,
Mann–Whitney test p> 0.05), even though in subjects with those
conditions VitD levels seemed somehow higher.
Tables 1, 2 show the correlation of VitD levels with
cardiometabolic (anthropometric and biochemical) parameters.
Serum 25 (OH) vitamin D levels had significant negative
correlations with age and HDL-cholesterol levels and had
significant positive correlations with body weight, BMI, FM,
FM%, limbs FM%, arms muscle mass, hip circumference, serum
triglycerides, GGT, AST, ALT, total cholesterol/HDL-cholesterol,
LDL-cholesterol/HDL-cholesterol, triglycerides/HDL-
cholesterol ratios, and ALT/AST ratio (Tables 1, 2). Leg
FM% was the anthropometric parameter that correlated most
with VitD levels. At the same time, the above-mentioned
biochemical variables had significant positive inter-correlations
with anthropometric parameters indicative of increased
adiposity (FM and FM%) and, surprisingly, some of them
more with indicators of peripheral (gluteo-femoral) rather
than with indicators of centripetal (truncal) adiposity (e.g.,
lipid levels correlated more with hip circumference and
leg FM%, than with waist circumference and trunk FM%,
Supplementary Table 1). Serum 25 (OH) VitD levels also
positively correlated with erythrocytes count and creatinine
(Table 3), while creatinine also had a positive correlation with
muscular mass (Supplementary Table 1).
To eliminate the possible confounding, we performed
Pearson’s and Spearman’s rank partial correlations. The
correlations with lipids, creatinine, and ALT remained
significant even after correcting for age, FM, and
FM%, but were lost after additional corrections for
leg FM% (with exception of total cholesterol/HDL-
cholesterol ratio, which only remained significant
correlation with VitD levels after this additional
correction) (Table 3).
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The stepwise linear regression analysis (which included age,
and biochemical and anthropometric data as predictor variables),
identified that the most significant predictors of VitD levels were
age, leg FM%, and triglyceride levels (the models 1 and 2 have
accounted for a statistically significant amount of VitD variance,
and explained 23.8 and 23% of VitD variance, respectively)
(Table 4).
DISCUSSION
This study is among the very rare ones that examined the levels
of VitD in a population of underground coal miners. We found
surprisingly high levels of late-summer serum 25 (OH) VitD,
which were much higher compared with the same season VitD
data on an urban-living, general male Serbian population from
similar geographic latitude (28), and previously published values
for coal miners from other geographic regions (18–21).
Apart from this, to the best of our knowledge, this is the first
published study that examined the association of VitD levels in
coal miners with their cardiometabolic status. Again, we have
found unexpected positive correlations with anthropometric data
and biochemical parameters indicative of obesity, metabolic
syndrome, and fatty liver disease, which is in contrast with
previously published data (28, 59).
Such unexpected findings require explanation and
more exploration.
The high levels of serum 25 (OH) vitamin D can be explained
by the late summer season (beginning of September) when
the serum levels of VitD are expected to be highest, and by
living in rural/semi-urban areas, with high isolation, where
additional agricultural work is quite common in that period
(leading to additional sun exposure during non-coal mining
working hours). Therefore, it would be necessary to examine
the winter/early spring levels of VitD in the same group, when
there would be much less sun exposure. The nutritional intake
of VitD in this study was quite low, and far below the current
EFSA recommendations, and only four subjects consumed VitD
supplements. Therefore, it could be expected to find much lower
values during winter/early spring.
However, the higher vitamin D levels can be also a
consequence of their heavy physical work, leading to increased
lipolysis and release of VitD from fat and muscular depots
(60–62). Studies indicate that serum VitD levels increase after
intensive physical activity (60, 63–65) and remain increased
even after 24 h (60, 63, 64). People who exercise regularly, even
indoors, have higher VitD levels compared with sedentary people
(60, 65–67). The data on increased VitD levels after weight loss
(accompanied by increased lipolysis) also support this hypothesis
(68). This can additionally explain the difference in VitD status
with the urban-living Serbian general male population, not
performing hard physical work, in which levels were almost
three times lower (49.8 ± 17.2 nmol/L), despite quite similar
BMI (28 ± 6.3 kg/m2), waist circumference (98.5 ± 18 cm), and
slightly higher FM% (24.8 ± 10.3%) (28). However, this cannot
explain the difference in VitD status with other published data on
summer VitD status in coal miners around the world (18–21).
The main explanations for the difference with the Newcastle
(UK) coal miners [where average values of 73.8 ± 73.4 nmol/L
were found during the summer period (18), which were two
times lower compared with these data] are geographic latitude
and the lower level of insolation, apart from the earlier time of
sampling (from May to July). In the study from India, samples
were taken over a whole year, not specified if summer or winter
(21), and in two other studies from UK and Turkey, the samples
were from the winter/early spring period (19, 20). Nevertheless,
the values in all those studies were much lower, particularly in
Turkish workers (20).
However, there can be some additional explanations for the
high vitamin D levels in the coal miners of this study.
In this study, vitD levels had a significant positive association
with alcohol intake the previous day. Nevertheless, it is quite
possible that the coal miners consciously withheld their alcohol
consumption both in the 24 h recalls and FFQs (since it was
an official medical checkup), and that their alcohol intake was
much higher, since some data place this profession among
the professions with highest alcohol consumption (21, 69, 70).
Several cross-sectional studies showed positive associations of
alcohol consumption with serum 25 (OH) VitD levels (66, 71–
74). Even though these could be confounding findings, there
can be a direct association between alcohol intake and VitD
metabolism. It was shown in rats that chronic alcohol intake
increases serum 25 (OH) VitD3, while it decreases serum 1, 25
(OH)2 VitD3 (75). The effect is most probably conveyed by a
direct inhibition of parathyroid hormone (PTH) secretion by
alcohol (76, 77). PTH stimulates the 1-alpha hydroxylation of
25 (OH) VitD3 to 1,25 (OH)2 VitD3. Nevertheless, only a small
fraction of 25 (OH) VitD3 is converted to 1,25 (OH)2 VitD3
(78), and it is less likely that the inhibited 1-alpha hydroxylation
significantly contributed to the considerably increased 25 (OH)
VitD3 levels in this study. In accordance, in one study, only about
a 10 nmol/L increase in serum 25 (OH) VitD was noted 5 years
after parathyroidectomy connected with significant decreases in
PTH (79). However, we cannot exclude the effect of habitual
alcohol consumption on VitD levels in this study, even though
regression models did not identify alcohol consumption as a
significant predictor of VitD levels.
Probably the most difficult is to explain the positive
association of vitamin D with the level of adiposity, triglycerides,
and liver enzymes indicative of fatty liver disease, and the
negative association with HDL-cholesterol. Most literature data
contrast with these findings and show the negative association
with the level of adiposity (3), blood lipids (80, 81), and liver
enzymes (82), even though there are also some conflicting
findings (1–4, 83).
In line with this study findings of increased prevalence of
obesity and metabolic disturbances among coal miners despite
their heavy physical activity, in a recent NHANES study, only
increased recreational physical activity was found to be associated
with an improved metabolic profile, while occupational physical
activity was not (84). In contrast, in a recent study of Chinese
coal miners, the higher level of occupational physical activity was
related to a decreased prevalence of metabolic syndrome among
them (23).
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TABLE 4 | Linear (stepwise) regression models for assessing the impact of specific characteristics of coal miners (general, anthropometric, biochemical, and nutritional)
on serum 25 (OH) vitamin D levels.
Model R2 Adjusted R2 Coefficients β B 95% CI for B
Lower bound Upper bound
1 0.268 0.238 (Constant) 58.609 [43.829, 73.388]**
Age −0.364 −0.630 [−0.947, −0.312]**
Legs FM% 0.279 0.719 [0.216, 1.221]**
Triglycerides 0.204 3.263 [0.433, 6.093]*
ALT 0.136 0.152 [−0.056, 0.359]
2 0.252 0.230 (Constant) 62.273 [48.292, 76.254]**
Age −0.390 −0.674 [−0.987, −0.361]**
Legs FM% 0.325 0.839 [0.361, 1.316]**
Triglycerides 0.220 3.529 [0.707, 6.351]*
*p < 0.05; regression coefficients are significant at the.05 level (two–tailed).
**p < 0.01; regression coefficients are significant at the 0.01 level (two–tailed).
FM%, percentage of fat mass; ALT, alanine aminotransferase; R2, coefficient of determination; β (beta), standardized linear regression coefficients; B, unstandardized linear regression
coefficients; CI, confidence intervals; p, statistical significance.
Even though most (almost 70%) of the subjects were
overweight and obese (according to BMI), only less than
half of them had increased adiposity, centripetal obesity, or
metabolic syndrome, which can be explained by the increased
muscular mass related to their heavy physical work and the
effect of physical activity on waist circumference and metabolic
parameters (85–87). However, in this study, hyperglycemia was
detected in more than 60%, while dyslipidemia (according to
at least one lipid parameter) was detected in even more than
80% of the study subjects. In accordance with this study,
in a study of Indian coal miners, serum triglycerides, total
cholesterol, very-low-density lipoproteins (VLDL)-cholesterol,
and LDL- cholesterol levels were found to be increased, while
HDL- cholesterol levels were found to be decreased, in the
coal miners compared with other workers, irrespective of the
level of adiposity, which suggests that some other factors
(inappropriate diet or working conditions, e.g., shift work)
additionally contribute to metabolic disturbances (22).
In this study, the most prevalent type of dyslipidemia was
hypertriglyceridemia. However, the levels of HDL-cholesterol
were not decreased in the same magnitude (only in one-quarter
of the subjects were they decreased), which can be explained by
the positive effect of heavy physical activity on HDL-cholesterol,
which is more sensitive to physical activity compared with LDL-
cholesterol and triglycerides (87).
The positive association of serum 25 (OH) vitamin D levels
with the levels of adiposity in this study can be explained
by increased lipolysis and VitD release from adipose tissue
depots during and after heavy physical work (60). Consistent
with this, in the study of Sun et al. (64), increased 25 (OH)
VitD levels after physical activity persisted for 24 h, and the
strongest positive predictor of the incremental area under
the curve was %FM, which is in agreement with the here
presented findings. In this study, there were also positive
correlations of VitD levels with limb muscle mass (although on
the borderline statistical significance), which also confirms that
muscular depots contribute to VitD status, although to a lesser
extent (60–62).
In adipose tissue, most of the stored vitamin D is in its
non-hydroxylated form (60). After the non-hydroxylated form
of VitD is released from fat and muscular depots, it binds to
a VitD binding protein, (DBP) and enters the liver where it
is activated (25–hydroxylated) and, without delay, is released
again into circulation, to be stored again in fat and muscular
depots (and other target organs), with a half-life of ∼2–3 weeks,
which ensures that the circulating 25 (OH) VitD levels are quite
stable and not significantly influenced by transient dietary intake
and sun exposure changes (60). This is in accordance with the
findings of this study that the previous day VitD intake did not
correlate with the measured 25 (OH) VitD levels.
The negative correlation of vitamin D status with age in this
study is in agreement with previously published data since older
people produce less cutaneous VitD3 (46), and we have used
age as a controlling factor to examine the association of VitD
with other parameters. Since in this study both VitD status and
different types of dyslipidemia had a positive association with the
level of adiposity (but not centripetal obesity), we used adiposity
parameters (FM and FM%) as additional controlling factors.
In the adjusted analyses, the associations with TG, HDL, lipid
ratios, ALT, and creatinine remained significant, as well with leg
FM%. Only after additionally correcting for leg FM% was the
significance of these associations with biochemical parameters
lost, indicating that leg FM% was an additional factor affecting
the association of VitD and biochemical parameters. Similarly,
in the regression analysis, the only significant predictors of VitD
status were age, leg FM%, and triglyceride levels.
The association with leg FM% can be explained by the fact
that leg (femoral) fat depots represent an important resource
of lipolysis during coal mining, even though the upper body
subcutaneous fat generally contributes more to lipolysis in men
during rest and exercise (88, 89). However, there are some
conflicting data, indicating that in younger overweight men (in
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contrast to older overweight men) femoral fat depots respond
more to exercise by lipolysis, compared with abdominal fat
depots, which was related to the initial size of the depot (89,
90). In addition, even though leg fat is considered to have a
more protective metabolic function and to be associated with
a more beneficial metabolic profile (88), the findings from this
study indicate the opposite. In this study, different types of
dyslipidemia had a positive association with the level of adiposity,
but, surprisingly, more with indicators of peripheral (gluteo-
femoral) rather than centripetal (truncal) adiposity (e.g., lipid
levels more correlated with hip circumference and leg FM% than
with waist circumference and trunk FM%).
Unfortunately, there are not enough data on the difference
between distinct subcutaneous and visceral fat depots in the
storage and release capacity for VitD, particularly on the
difference between distinct subcutaneous depots (60, 91). In one
study (91), the concentrations of the non-hydroxylated form of
VitD in visceral fat depots were moderately higher compared
with abdominal subcutaneous fat depots, in both obese and non-
obese women (with no difference between them). Nevertheless,
considering a significantly larger amount of subcutaneous fat
depots (4–6-fold), these depots contribute the most to circulating
VitD levels (60).
On the other hand, the association of vitD with adipose tissue
is bidirectional, and vitD can influence fat accumulation and
re-distribution: in one study (92), supplementation with VitD
decreased truncal subcutaneous fat without changing total fat
mass, and this effect can be attributed to the direct effects of VitD
on adipose tissue (probably through adipose tissue VitD receptor
actions, or through its effects on calcium metabolism) and lower
PTH levels (93–96).
Since high 25 (OH) vitD3 levels have a reverse relationship
with PTH levels (78), we suppose that in the population of coal
miners (with high VitD levels), the levels of PTH were lower
than in the general Serbian male population. PTH is known
to simulate truncal fat distribution, thus centripetal obesity
and related metabolic disturbances (i.e., metabolic syndrome)
are often observed in primary hyperparathyroidism (79, 97–
99). Therefore, lowering the levels of PTH can lead to a more
favorable peripheral fat distribution and metabolic profile (79,
98, 99). Increased/decreased PTH secretion can be a possible
explanation for commonly observed negative relationships of
serum VitD with centripetal obesity and metabolic syndrome
(28) and the in this study found positive association with
peripheral fat accumulation (hip circumference and leg FM%).
Unfortunately, we did not measure the levels of PTH in this
study, as it was not originally planned in the study design to
measure PTH, and even though (after measuring VitD) we had
some leftovers of the serum samples of coal miners, with an
adequate quantity for PTH measurements, the low stability of
PTH in the serum samples during long-term storage (100) did
not allow us to perform reliable measurements. Nevertheless, in
this study, three-quarters of the coal miners had a centripetal
body fat distribution (according to WHR), despite the very high
levels of VitD (and probably low levels of PTH), and there was
no association of VitD with WHR or waist circumference, which
indicates that the role of VitD and PTH on body fat distribution
was insignificant in the coal miners. This is in accordance with
data on the imperceptible effects of VitD on obesity treatment
(94, 101) and with data that show that in subjects with high levels
of VitD, there is no effect of additional supplementation with
VitD on body fat re-distribution (96, 101).
Particularly interesting is the finding of a positive association
of serum 25 (OH) VitD levels with serum triglycerides levels.
In general, most of the published data (but not all) indicate
a negative association of VitD with triglyceride levels, and
a positive association with HDL-cholesterol levels (80, 81).
Triglycerides and HDL-cholesterol generally have an inverse
association (102, 103), which we confirmed in this study
(Spearman’s coefficient of correlation = −0.615, p < 0.001),
and the linear regression analysis identified only triglycerides
as significant predictors of VitD levels. Interestingly, and in
line with this study findings, some studies show that VitD
supplementation increased the levels of triglycerides (104–106),
even though both unchanged (107–109) and decreased (110)
levels were found in other studies. Therefore, we hypothesize
that the observed positive relationship of VitD with serum
triglycerides reflects the effect of positive association with
lipolysis after an enduring physical work (89). The increased
lipolysis during prolonged physical work not only increases the
release of VitD from adipose and muscular depots but also
increases the supply of free fatty acids (FFAs), released from
fat tissue, to the liver. In the liver, accumulated FFAs stimulate
the production and secretion of VLDL, the main transporters of
serum triglycerides, which are consequently cleared, mostly by
muscle and adipose tissue (89, 111).
In general, under fasting and resting conditions, circulating
triglycerides are in direct proportion with the rates of release
and oxidation of FFAs (111). After physical activity, lipolysis is
still increased, and this effect can last up to 24 to 42 h (89, 112,
113). The increased FFAs’ release after physical activity increase
the FFAs’ supply to the liver. The increased supply of FFAs to
the liver increases triglycerides secretion from the liver (in the
form of VLDL) (111), but one could expect that triglycerides
will be rapidly cleared from circulation by lipoprotein lipase
(LPL), whose activity in a muscle is concomitantly increased
during recovery after a physical activity (87), which would lead
to a drop in triglycerides levels. However, quite the opposite,
increases in triglyceride levels have also been described several
hours after physical activity, indicating that their increased
production can prevail over their increased clearance (87, 114).
In accordance, the increased FFAs supply to muscle and fat tissue
after physical activity can interfere with triglyceride clearance
by LPL (111). Alcohol consumption additionally decreases LPL
activity (115). Finally, studies show that total energy replacement
after physical activity (what coal miners do after their work)
diminishes/completely abolishes the beneficial effects of the
physical activity on the next-day fasting and postprandial
triglyceride and HDL-cholesterol levels (87, 114, 116, 117).
Nevertheless, these hypotheses need to be confirmed by
further studies, and there can also be other mechanisms of
the found associations of VitD levels with cardiometabolic
parameters.
In accordance with the present study findings of high vitD
values associated with worse metabolic profile among coal
miners, some studies show a U-shaped association of VitD levels
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with cardiovascular mortality and risk, which requires further
investigation (46).
Although not a primary aim of this study, the positive
correlation of VitD with creatinine can be explained by the
confounding effect of increased physical activity and release from
muscular depots, since after a heavy physical activity the levels of
creatinine also increase (118, 119), apart from the levels of VitD.
Similarly, after heavy physical activity, the levels of ALT, AST, and
GGT increase and can stay increased even after 24 h (118). The
positive correlation with erythrocyte number could be explained
by the direct effects of VitD on erythropoiesis and/or erythrocytes
survival (120, 121), but can also be another confounding effect of
physical activity (connected with increased erythrocyte release,
due to splenic contraction, and hemoconcentration) (122).
This study has several limitations. The main limitation of this
study is that only the late summer VitD levels are measured,
without additional measurements of the winter/early spring VitD
levels [which are expected to be much lower (19, 20)]. An
additional limitation is the non-existence of a direct control
group of non-coal miners from the same area, matched by
sex, age, and anthropometric variables. However, we compared
the data with recent literature findings for the Serbian general
male population (urban-living and not working in physically
demanding jobs but with similar age and anthropometric
features), even though the method for VitD measurement
(chemiluminescent immunoassay, CLIA) and the month and
year of study sampling (July 2014) were not the same (28).
Nevertheless, we had some serum samples from a small group of
urban-living general population from the same latitude, from the
beginning of September 2016 (the same as in the present study)
and analyzed by HPLC at the same time with the samples from
the coal miners, but that group was very small and mostly made
of women (22 women and two men), and the data only served
for HPLC method verification. The mean values in this group
were 55.1 ± 30.9 nmol/L, again almost three times lower than
in the coal miners and similar to data in reference (28). Another
limitation is that the sample of the miners was not randomly
taken (as it was a part of systematic medical examinations of all
employed coal miners from one coal mine/shaft in the Resavica
basin) and was only from one region for coal mining in Serbia,
but we think that also in other regions situation will be quite
similar (since they are very near geographically), and the most
of Serbian coal miners work in the sampled region (76.4%) (27).
Furthermore, we performed HPLC, but liquid chromatography-
tandem mass spectrometry (LC-MS/MS) is the gold standard
for VitD measurement (46, 78). We did not measure PTH
levels, nor the free (i.e., bioavailable, not bound with DBP) VitD
form, the active form of VitD (1,25 (OH)2 VitD), other VitD
metabolites or epimers (e.g., C-3 epimers), which could modify
or more explain these results (63, 78). In addition, some data
show that VACUETTE R© tubes with a serum clot activator can
interfere with immunoassays for 25 (OH) VitD measurements
(123, 124), but there are no such data on the HPLC method
with Vacutest Kima R© tubes with a serum clot activator (125), and
even though a bit higher values were observed in immunoassays
with VACUETTE R© tubes with a serum clot activator, they
correlated well with the ones measured by LC-MS/MS (123,
124). Moreover, TANITA BIA segmental analysis is not that
accurate and precise in assessing regional body composition as
other methods (e.g., dual-energy X-ray absorptiometry, DXA;
computerized tomography, CT; magnetic resonance imaging,
MRI), particularly in some populations (126). However, the
mentioned techniques are costly and cannot be easily applied
in field settings, and there is still a fairly good estimation with
an eight-contact electrode BIA system, as confirmed by some
validity studies (34). Finally, we did not directly measure or
precisely estimate the level of individual physical activity, since
it was not initially planned. Nevertheless, we controlled for
physical activity in the questionnaire. All the coal miners were
asked about their self-reported physical activity levels and the
specific jobs they perform during coal mining. All of them were
involved in hewing coal, loading coal, or (to a much lesser
extent) erecting roof supports, and were placed in the heavy
occupational work physical activity level (PAL) category (31).
There are some publications which describe physical activities
and directly measure physical activity and energy expenditures
during coal mining (25, 127), and there was no huge difference
between hewing coal and loading coal in energy expenditure.
Nevertheless, it would be of interest to directly measure or at least
precisely estimate the individual level of physical activity, and to
relate it to individual VitD status in coal miners, to support the
presented hypotheses.
Coal miners are a population of workers with specific
nutritional needs due to their heavy physical work and
unfavorable working conditions: working in shifts, working
underground, and working with chronic occupational exposure
to coal mine dust, which has pro-oxidative, pro-inflammatory,
and pro-cancerogenic properties (128–130). Therefore, in the
view of the science of precision nutrition, measuring the levels
of VitD (which has the important metabolic, antioxidant, and
anti-inflammatory activities) is very important in this population
of workers to achieve their optimal nutrition, to adjust their
nutrition (and possible supplementation) and meet their specific
nutritional needs (131).
Considering the unexpected findings of this study, which are
not easy to explain, and the above-mentioned study limitations,
more studies are warranted to confirm the results and further
explore the topic of VitD status and cardiometabolic health
among coal miners.
CONCLUSION
In this study, we have found surprisingly high levels of late
summer serum 25 (OH) VitD in a population of Serbian coal
miners, much higher compared with the same season VitD
data from an urban-living Serbian general male population with
similar anthropometric characteristics, and previously published
data for coal miners from other countries. Furthermore, we
have found unexpected positive correlations of serum 25 (OH)
VitD levels with anthropometric and biochemical parameters
indicative of obesity, metabolic syndrome, and fatty liver
disease. The linear regression analysis identified that the most
significant positive predictors of VitD levels were age, leg FM%,
and triglyceride levels. Such unexpected findings require more
exploration. Data on VitD levels in the population of coal miners
are scarce, as well as data on their cardiometabolic health.
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More research is needed on the VitD status of coal miners
(particularly in the winter period) and its relationship with their
cardiometabolic status.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by Institute of Occupational Health Niš Ethics
Board. The patients/participants provided their written informed
consent to participate in this study.
AUTHOR CONTRIBUTIONS
IS wrote the manuscript and performed anthropometric
measurements, nutritional interviews, software exploration
of nutritional data, biochemical analyses, and all the
statistical analyses. JJ organized and performed preventive
medical examinations, clinical assessments of coal miners,
and biochemical analyses. MZec and ZP performed VitD
measurements by HPLC. JD-M performed biochemical analyses.
MZek and JM were involved in the dietary assessment. MGu and
MGl led the project under which the study was conducted. All
authors contributed to the writing of the manuscript.
FUNDING
The authors acknowledge the financial support from theMinistry
of Education, Science and Technological Development of the
Republic of Serbia, project number III41030 (2011–2017) and
ongoing contract number: 451-03-9/2021-14/200015.
ACKNOWLEDGMENTS
The authors are grateful to Dr. Agnes Kadvan for their
involvement in dietary assessments.
SUPPLEMENTARY MATERIAL




1. Wimalawansa SJ. Associations of Vitamin D with insulin resistance, obesity,
Type 2 diabetes, and metabolic syndrome. J Steroid BiochemMol Biol. (2018)
175:177–89. doi: 10.1016/j.jsbmb.2016.09.017
2. Durgarao Y, Manjrekar PA, Adhikari P, Chakrapani M, Rukmini MS.
Comprehensive review on diabetes associated cardiovascular complications
- the Vitamin D perspective. Cardiovasc Hematol Disord Drug Targets. (2019)
19:139–53. doi: 10.2174/1871529X19666190114155302
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